Agilent Technologies Inc. (Santa Clara, California) has agreed to purchase Varian, Inc. (Palo Alto, California) for $1.5 billion or $52 per share.
Agilent Technologies Inc. (Santa Clara, California) has agreed to purchase Varian, Inc. (Palo Alto, California) for $1.5 billion or $52 per share. According to Agilent, the acquisition broadens its applications and solutions offerings in life sciences, environmental, and energy and materials. It also expands the company’s product portfolio into atomic and molecular spectroscopy; establishes a leading position in NMR, imaging, and vacuum technologies; and strengthens its consumables portfolio.
“This acquisition is a major step in Agilent’s transformation into a leading bio-analytical measurement company,” said Bill Sullivan, Agilent’s president and chief executive officer.
The transaction is expected to generate $75 million in annual cost synergies and achieve Agilent’s 20% return on invested capital (ROIC) target within four to five years. The transaction is subject to approval by the shareholders of Varian and will be completed after achieving customary closing conditions and regulatory approvals, which Agilent expects before calendar year-end.
Best of the Week: EAS Conference Coverage, IR Spectroscopy, Microplastics
November 22nd 2024Top articles published this week include highlights from the Eastern Analytical Symposium, a news article about the infrared (IR) spectroscopy market, and a couple of news articles recapping spectroscopic analysis of microplastics.
FT-IR Analysis of pH and Xylitol Driven Conformational Changes of Ovalbumin–Amide VI Band Study
November 21st 2024This study uses Fourier transform infrared (FT-IR) spectroscopy to analyze how the globular protein ovalbumin's secondary structures transition under varying pH conditions in the presence of the cosolvent xylitol, highlighting the role of noncovalent interactions in these conformational changes.